nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrimeprazine—DRD4—conduct disorder	0.597	0.684	CbGaD
Methotrimeprazine—HTR2A—conduct disorder	0.275	0.316	CbGaD
Methotrimeprazine—HTR2A—autonomic nervous system—conduct disorder	0.00101	0.188	CbGeAlD
Methotrimeprazine—Propiomazine—DRD4—conduct disorder	0.000546	0.0852	CrCbGaD
Methotrimeprazine—DRD4—brain—conduct disorder	0.000497	0.0929	CbGeAlD
Methotrimeprazine—Cyamemazine—HTR2A—conduct disorder	0.00049	0.0765	CrCbGaD
Methotrimeprazine—Promazine—DRD4—conduct disorder	0.000404	0.0631	CrCbGaD
Methotrimeprazine—CHRM4—brain—conduct disorder	0.000376	0.0703	CbGeAlD
Methotrimeprazine—Chlorpromazine—DRD4—conduct disorder	0.000356	0.0556	CrCbGaD
Methotrimeprazine—DRD3—brain—conduct disorder	0.000349	0.0653	CbGeAlD
Methotrimeprazine—DRD5—brain—conduct disorder	0.000328	0.0612	CbGeAlD
Methotrimeprazine—Acepromazine—HTR2A—conduct disorder	0.000315	0.0491	CrCbGaD
Methotrimeprazine—Clomipramine—SLC6A4—conduct disorder	0.000311	0.0486	CrCbGaD
Methotrimeprazine—Thioproperazine—HTR2A—conduct disorder	0.000308	0.048	CrCbGaD
Methotrimeprazine—Pipotiazine—HTR2A—conduct disorder	0.000303	0.0473	CrCbGaD
Methotrimeprazine—Mesoridazine—HTR2A—conduct disorder	0.000299	0.0466	CrCbGaD
Methotrimeprazine—CHRM5—brain—conduct disorder	0.000294	0.0549	CbGeAlD
Methotrimeprazine—Trimipramine—SLC6A4—conduct disorder	0.000286	0.0447	CrCbGaD
Methotrimeprazine—ADRA1B—brain—conduct disorder	0.000268	0.0502	CbGeAlD
Methotrimeprazine—ADRA1D—brain—conduct disorder	0.000263	0.0491	CbGeAlD
Methotrimeprazine—Fluphenazine—HTR2A—conduct disorder	0.000262	0.0408	CrCbGaD
Methotrimeprazine—Propiomazine—HTR2A—conduct disorder	0.000252	0.0393	CrCbGaD
Methotrimeprazine—DRD1—brain—conduct disorder	0.00025	0.0468	CbGeAlD
Methotrimeprazine—Clomipramine—HTR2A—conduct disorder	0.000239	0.0374	CrCbGaD
Methotrimeprazine—Chlorprothixene—HTR2A—conduct disorder	0.000238	0.0372	CrCbGaD
Methotrimeprazine—Thioridazine—HTR2A—conduct disorder	0.000225	0.0352	CrCbGaD
Methotrimeprazine—Trimipramine—HTR2A—conduct disorder	0.00022	0.0344	CrCbGaD
Methotrimeprazine—Imipramine—SLC6A4—conduct disorder	0.000212	0.0332	CrCbGaD
Methotrimeprazine—Promethazine—HTR2A—conduct disorder	0.000212	0.0331	CrCbGaD
Methotrimeprazine—Trifluoperazine—HTR2A—conduct disorder	0.000209	0.0326	CrCbGaD
Methotrimeprazine—Perphenazine—HTR2A—conduct disorder	0.000207	0.0323	CrCbGaD
Methotrimeprazine—CHRM2—brain—conduct disorder	0.000202	0.0377	CbGeAlD
Methotrimeprazine—HTR2C—brain—conduct disorder	0.000194	0.0363	CbGeAlD
Methotrimeprazine—Promazine—HTR2A—conduct disorder	0.000186	0.0291	CrCbGaD
Methotrimeprazine—CHRM1—brain—conduct disorder	0.000184	0.0343	CbGeAlD
Methotrimeprazine—CHRM3—brain—conduct disorder	0.000164	0.0307	CbGeAlD
Methotrimeprazine—Chlorpromazine—HTR2A—conduct disorder	0.000164	0.0256	CrCbGaD
Methotrimeprazine—Imipramine—HTR2A—conduct disorder	0.000163	0.0255	CrCbGaD
Methotrimeprazine—ADRA1A—brain—conduct disorder	0.000151	0.0282	CbGeAlD
Methotrimeprazine—DRD2—brain—conduct disorder	0.000148	0.0276	CbGeAlD
Methotrimeprazine—ADRA2C—brain—conduct disorder	0.000144	0.0269	CbGeAlD
Methotrimeprazine—HRH1—brain—conduct disorder	0.000117	0.0218	CbGeAlD
Methotrimeprazine—ADRA2A—brain—conduct disorder	0.000115	0.0214	CbGeAlD
Methotrimeprazine—CYP2E1—brain—conduct disorder	0.000112	0.021	CbGeAlD
Methotrimeprazine—HTR2A—brain—conduct disorder	9.75e-05	0.0182	CbGeAlD
Methotrimeprazine—CYP2D6—brain—conduct disorder	8.88e-05	0.0166	CbGeAlD
Methotrimeprazine—HRH1—GPCR ligand binding—DRD4—conduct disorder	8.7e-05	0.000746	CbGpPWpGaD
Methotrimeprazine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	8.67e-05	0.000744	CbGpPWpGaD
Methotrimeprazine—CHRM1—GPCR ligand binding—DRD4—conduct disorder	8.67e-05	0.000744	CbGpPWpGaD
Methotrimeprazine—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	8.64e-05	0.000742	CbGpPWpGaD
Methotrimeprazine—CHRM3—GPCR ligand binding—DRD4—conduct disorder	8.64e-05	0.000741	CbGpPWpGaD
Methotrimeprazine—CHRM2—GPCR downstream signaling—CGA—conduct disorder	8.64e-05	0.000741	CbGpPWpGaD
Methotrimeprazine—ADRA1A—GPCR downstream signaling—CGA—conduct disorder	8.61e-05	0.000739	CbGpPWpGaD
Methotrimeprazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.6e-05	0.000738	CbGpPWpGaD
Methotrimeprazine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	8.56e-05	0.000734	CbGpPWpGaD
Methotrimeprazine—CHRM2—GPCR ligand binding—DRD4—conduct disorder	8.56e-05	0.000734	CbGpPWpGaD
Methotrimeprazine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	8.54e-05	0.000732	CbGpPWpGaD
Methotrimeprazine—ADRA1A—GPCR ligand binding—DRD4—conduct disorder	8.54e-05	0.000732	CbGpPWpGaD
Methotrimeprazine—DRD4—GPCR ligand binding—HTR2A—conduct disorder	8.51e-05	0.00073	CbGpPWpGaD
Methotrimeprazine—DRD4—Circadian rythm related genes—EP300—conduct disorder	8.43e-05	0.000723	CbGpPWpGaD
Methotrimeprazine—CHRM4—GPCR ligand binding—HTR2A—conduct disorder	8.39e-05	0.00072	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.37e-05	0.000718	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.23e-05	0.000706	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—CGA—conduct disorder	8.12e-05	0.000696	CbGpPWpGaD
Methotrimeprazine—CHRM5—GPCR ligand binding—HTR2A—conduct disorder	8.04e-05	0.000689	CbGpPWpGaD
Methotrimeprazine—ADRA2A—GPCR downstream signaling—CGA—conduct disorder	8e-05	0.000687	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—CGA—conduct disorder	7.99e-05	0.000685	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—CGA—conduct disorder	7.97e-05	0.000684	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—CGA—conduct disorder	7.95e-05	0.000682	CbGpPWpGaD
Methotrimeprazine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	7.93e-05	0.00068	CbGpPWpGaD
Methotrimeprazine—ADRA2A—GPCR ligand binding—DRD4—conduct disorder	7.93e-05	0.00068	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—CGA—conduct disorder	7.92e-05	0.000679	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—CGA—conduct disorder	7.84e-05	0.000673	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—CGA—conduct disorder	7.82e-05	0.000671	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—WASF1—conduct disorder	7.66e-05	0.000657	CbGpPWpGaD
Methotrimeprazine—DRD1—GPCR ligand binding—HTR2A—conduct disorder	7.66e-05	0.000657	CbGpPWpGaD
Methotrimeprazine—DRD1—Circadian rythm related genes—EP300—conduct disorder	7.59e-05	0.000651	CbGpPWpGaD
Methotrimeprazine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	7.59e-05	0.000651	CbGpPWpGaD
Methotrimeprazine—DRD3—GPCR ligand binding—HTR2A—conduct disorder	7.56e-05	0.000648	CbGpPWpGaD
Methotrimeprazine—ADRA1D—GPCR ligand binding—HTR2A—conduct disorder	7.56e-05	0.000648	CbGpPWpGaD
Methotrimeprazine—DRD3—Circadian rythm related genes—EP300—conduct disorder	7.49e-05	0.000643	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Biological oxidations—COMT—conduct disorder	7.48e-05	0.000642	CbGpPWpGaD
Methotrimeprazine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	7.45e-05	0.000639	CbGpPWpGaD
Methotrimeprazine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	7.43e-05	0.000637	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Biological oxidations—MAOA—conduct disorder	7.43e-05	0.000637	CbGpPWpGaD
Methotrimeprazine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	7.41e-05	0.000635	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metapathway biotransformation—COMT—conduct disorder	7.38e-05	0.000633	CbGpPWpGaD
Methotrimeprazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	7.33e-05	0.000629	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	7.31e-05	0.000627	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—CGA—conduct disorder	7.27e-05	0.000623	CbGpPWpGaD
Methotrimeprazine—CHRM4—GPCR downstream signaling—DRD4—conduct disorder	7.27e-05	0.000623	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—CGA—conduct disorder	7.06e-05	0.000605	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—CGA—conduct disorder	6.96e-05	0.000597	CbGpPWpGaD
Methotrimeprazine—CHRM5—GPCR downstream signaling—DRD4—conduct disorder	6.96e-05	0.000597	CbGpPWpGaD
Methotrimeprazine—HTR2A—SIDS Susceptibility Pathways—EP300—conduct disorder	6.91e-05	0.000593	CbGpPWpGaD
Methotrimeprazine—ADRA2B—GPCR ligand binding—HTR2A—conduct disorder	6.82e-05	0.000585	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	6.8e-05	0.000583	CbGpPWpGaD
Methotrimeprazine—CHRM2—SIDS Susceptibility Pathways—EP300—conduct disorder	6.78e-05	0.000582	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—CGA—conduct disorder	6.67e-05	0.000572	CbGpPWpGaD
Methotrimeprazine—DRD1—GPCR downstream signaling—DRD4—conduct disorder	6.63e-05	0.000569	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling by GPCR—DRD4—conduct disorder	6.6e-05	0.000566	CbGpPWpGaD
Methotrimeprazine—HTR2C—GPCR ligand binding—HTR2A—conduct disorder	6.55e-05	0.000562	CbGpPWpGaD
Methotrimeprazine—ADRA1D—GPCR downstream signaling—DRD4—conduct disorder	6.54e-05	0.000561	CbGpPWpGaD
Methotrimeprazine—DRD3—GPCR downstream signaling—DRD4—conduct disorder	6.54e-05	0.000561	CbGpPWpGaD
Methotrimeprazine—DRD5—GPCR downstream signaling—HTR2A—conduct disorder	6.51e-05	0.000559	CbGpPWpGaD
Methotrimeprazine—ADRA2C—GPCR ligand binding—HTR2A—conduct disorder	6.37e-05	0.000547	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	6.37e-05	0.000546	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—CGA—conduct disorder	6.35e-05	0.000545	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Metabolism—CGA—conduct disorder	6.32e-05	0.000542	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling by GPCR—DRD4—conduct disorder	6.32e-05	0.000542	CbGpPWpGaD
Methotrimeprazine—ADRA1B—GPCR ligand binding—HTR2A—conduct disorder	6.27e-05	0.000538	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—CGA—conduct disorder	6.27e-05	0.000538	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—CGA—conduct disorder	6.27e-05	0.000538	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling by GPCR—DRD4—conduct disorder	6.02e-05	0.000517	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling by GPCR—DRD4—conduct disorder	5.94e-05	0.00051	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling by GPCR—DRD4—conduct disorder	5.94e-05	0.00051	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling by GPCR—HTR2A—conduct disorder	5.91e-05	0.000507	CbGpPWpGaD
Methotrimeprazine—ADRA2B—GPCR downstream signaling—DRD4—conduct disorder	5.91e-05	0.000507	CbGpPWpGaD
Methotrimeprazine—DRD2—GPCR ligand binding—HTR2A—conduct disorder	5.78e-05	0.000496	CbGpPWpGaD
Methotrimeprazine—DRD2—Circadian rythm related genes—EP300—conduct disorder	5.73e-05	0.000492	CbGpPWpGaD
Methotrimeprazine—HRH1—GPCR ligand binding—HTR2A—conduct disorder	5.68e-05	0.000487	CbGpPWpGaD
Methotrimeprazine—HTR2C—GPCR downstream signaling—DRD4—conduct disorder	5.67e-05	0.000487	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—CGA—conduct disorder	5.66e-05	0.000485	CbGpPWpGaD
Methotrimeprazine—CHRM1—GPCR ligand binding—HTR2A—conduct disorder	5.66e-05	0.000485	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—WASF1—conduct disorder	5.66e-05	0.000485	CbGpPWpGaD
Methotrimeprazine—CHRM3—GPCR ligand binding—HTR2A—conduct disorder	5.64e-05	0.000484	CbGpPWpGaD
Methotrimeprazine—CHRM1—Circadian rythm related genes—EP300—conduct disorder	5.61e-05	0.000481	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—CGA—conduct disorder	5.6e-05	0.00048	CbGpPWpGaD
Methotrimeprazine—CHRM2—GPCR ligand binding—HTR2A—conduct disorder	5.59e-05	0.000479	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—WASF1—conduct disorder	5.58e-05	0.000479	CbGpPWpGaD
Methotrimeprazine—ADRA1A—GPCR ligand binding—HTR2A—conduct disorder	5.57e-05	0.000478	CbGpPWpGaD
Methotrimeprazine—ADRA2C—GPCR downstream signaling—DRD4—conduct disorder	5.52e-05	0.000473	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—CGA—conduct disorder	5.43e-05	0.000466	CbGpPWpGaD
Methotrimeprazine—ADRA1B—GPCR downstream signaling—DRD4—conduct disorder	5.43e-05	0.000466	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling by GPCR—DRD4—conduct disorder	5.36e-05	0.00046	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—DRD4—conduct disorder	5.35e-05	0.000459	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—WASF1—conduct disorder	5.34e-05	0.000458	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—CGA—conduct disorder	5.29e-05	0.000453	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—CGA—conduct disorder	5.2e-05	0.000446	CbGpPWpGaD
Methotrimeprazine—ADRA2A—GPCR ligand binding—HTR2A—conduct disorder	5.18e-05	0.000444	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling by GPCR—DRD4—conduct disorder	5.15e-05	0.000442	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—CGA—conduct disorder	5.14e-05	0.00044	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—WASF1—conduct disorder	5.09e-05	0.000437	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—WASF1—conduct disorder	5.02e-05	0.000431	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—WASF1—conduct disorder	5.02e-05	0.000431	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling by GPCR—DRD4—conduct disorder	5.01e-05	0.00043	CbGpPWpGaD
Methotrimeprazine—DRD2—GPCR downstream signaling—DRD4—conduct disorder	5.01e-05	0.00043	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling by GPCR—DRD4—conduct disorder	4.93e-05	0.000423	CbGpPWpGaD
Methotrimeprazine—HTR2A—GPCR downstream signaling—DRD4—conduct disorder	4.93e-05	0.000423	CbGpPWpGaD
Methotrimeprazine—HRH1—GPCR downstream signaling—DRD4—conduct disorder	4.92e-05	0.000422	CbGpPWpGaD
Methotrimeprazine—CHRM1—GPCR downstream signaling—DRD4—conduct disorder	4.9e-05	0.00042	CbGpPWpGaD
Methotrimeprazine—CHRM3—GPCR downstream signaling—DRD4—conduct disorder	4.88e-05	0.000419	CbGpPWpGaD
Methotrimeprazine—CHRM2—GPCR downstream signaling—DRD4—conduct disorder	4.84e-05	0.000415	CbGpPWpGaD
Methotrimeprazine—ADRA1A—GPCR downstream signaling—DRD4—conduct disorder	4.82e-05	0.000414	CbGpPWpGaD
Methotrimeprazine—DRD4—GPCR downstream signaling—HTR2A—conduct disorder	4.81e-05	0.000412	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—CGA—conduct disorder	4.8e-05	0.000411	CbGpPWpGaD
Methotrimeprazine—CHRM4—GPCR downstream signaling—HTR2A—conduct disorder	4.74e-05	0.000407	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—CGA—conduct disorder	4.72e-05	0.000405	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—CGA—conduct disorder	4.72e-05	0.000404	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—CGA—conduct disorder	4.71e-05	0.000404	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—CGA—conduct disorder	4.69e-05	0.000403	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—CGA—conduct disorder	4.68e-05	0.000401	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—CGA—conduct disorder	4.63e-05	0.000397	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—CGA—conduct disorder	4.62e-05	0.000396	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—DRD4—conduct disorder	4.55e-05	0.00039	CbGpPWpGaD
Methotrimeprazine—CHRM5—GPCR downstream signaling—HTR2A—conduct disorder	4.54e-05	0.00039	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—WASF1—conduct disorder	4.54e-05	0.000389	CbGpPWpGaD
Methotrimeprazine—ADRA2A—GPCR downstream signaling—DRD4—conduct disorder	4.48e-05	0.000384	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—DRD4—conduct disorder	4.47e-05	0.000384	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—DRD4—conduct disorder	4.46e-05	0.000383	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—DRD4—conduct disorder	4.45e-05	0.000382	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—DRD4—conduct disorder	4.44e-05	0.000381	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—DRD4—conduct disorder	4.39e-05	0.000377	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—DRD4—conduct disorder	4.38e-05	0.000376	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling by GPCR—HTR2A—conduct disorder	4.36e-05	0.000374	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—WASF1—conduct disorder	4.36e-05	0.000374	CbGpPWpGaD
Methotrimeprazine—DRD1—GPCR downstream signaling—HTR2A—conduct disorder	4.33e-05	0.000371	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling by GPCR—HTR2A—conduct disorder	4.31e-05	0.000369	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—CGA—conduct disorder	4.29e-05	0.000368	CbGpPWpGaD
Methotrimeprazine—DRD3—GPCR downstream signaling—HTR2A—conduct disorder	4.27e-05	0.000366	CbGpPWpGaD
Methotrimeprazine—ADRA1D—GPCR downstream signaling—HTR2A—conduct disorder	4.27e-05	0.000366	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—WASF1—conduct disorder	4.24e-05	0.000363	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—WASF1—conduct disorder	4.17e-05	0.000358	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling by GPCR—HTR2A—conduct disorder	4.12e-05	0.000354	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—DRD4—conduct disorder	4.07e-05	0.000349	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling by GPCR—HTR2A—conduct disorder	3.93e-05	0.000337	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—DRD4—conduct disorder	3.9e-05	0.000334	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling by GPCR—HTR2A—conduct disorder	3.88e-05	0.000333	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling by GPCR—HTR2A—conduct disorder	3.88e-05	0.000333	CbGpPWpGaD
Methotrimeprazine—ADRA2B—GPCR downstream signaling—HTR2A—conduct disorder	3.85e-05	0.000331	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—WASF1—conduct disorder	3.84e-05	0.00033	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—WASF1—conduct disorder	3.78e-05	0.000324	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—WASF1—conduct disorder	3.77e-05	0.000324	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—WASF1—conduct disorder	3.76e-05	0.000323	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—WASF1—conduct disorder	3.75e-05	0.000322	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—DRD4—conduct disorder	3.73e-05	0.00032	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—WASF1—conduct disorder	3.71e-05	0.000319	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—WASF1—conduct disorder	3.7e-05	0.000318	CbGpPWpGaD
Methotrimeprazine—HTR2C—GPCR downstream signaling—HTR2A—conduct disorder	3.7e-05	0.000318	CbGpPWpGaD
Methotrimeprazine—ADRA2C—GPCR downstream signaling—HTR2A—conduct disorder	3.6e-05	0.000309	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—DRD4—conduct disorder	3.56e-05	0.000305	CbGpPWpGaD
Methotrimeprazine—ADRA1B—GPCR downstream signaling—HTR2A—conduct disorder	3.54e-05	0.000304	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—DRD4—conduct disorder	3.51e-05	0.000301	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—DRD4—conduct disorder	3.51e-05	0.000301	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling by GPCR—HTR2A—conduct disorder	3.5e-05	0.0003	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—HTR2A—conduct disorder	3.49e-05	0.0003	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—WASF1—conduct disorder	3.44e-05	0.000295	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling by GPCR—HTR2A—conduct disorder	3.36e-05	0.000288	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—CGA—conduct disorder	3.35e-05	0.000287	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling by GPCR—HTR2A—conduct disorder	3.27e-05	0.00028	CbGpPWpGaD
Methotrimeprazine—DRD2—GPCR downstream signaling—HTR2A—conduct disorder	3.27e-05	0.00028	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Hemostasis—EP300—conduct disorder	3.23e-05	0.000277	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling by GPCR—HTR2A—conduct disorder	3.22e-05	0.000276	CbGpPWpGaD
Methotrimeprazine—HRH1—GPCR downstream signaling—HTR2A—conduct disorder	3.21e-05	0.000275	CbGpPWpGaD
Methotrimeprazine—CHRM1—GPCR downstream signaling—HTR2A—conduct disorder	3.2e-05	0.000274	CbGpPWpGaD
Methotrimeprazine—CHRM3—GPCR downstream signaling—HTR2A—conduct disorder	3.19e-05	0.000273	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—DRD4—conduct disorder	3.17e-05	0.000272	CbGpPWpGaD
Methotrimeprazine—CHRM2—GPCR downstream signaling—HTR2A—conduct disorder	3.16e-05	0.000271	CbGpPWpGaD
Methotrimeprazine—ADRA1A—GPCR downstream signaling—HTR2A—conduct disorder	3.15e-05	0.00027	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—DRD4—conduct disorder	3.04e-05	0.000261	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Hemostasis—EP300—conduct disorder	3.02e-05	0.000259	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—HTR2A—conduct disorder	2.97e-05	0.000254	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—DRD4—conduct disorder	2.96e-05	0.000254	CbGpPWpGaD
Methotrimeprazine—ADRA2A—GPCR downstream signaling—HTR2A—conduct disorder	2.92e-05	0.000251	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—DRD4—conduct disorder	2.91e-05	0.00025	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—HTR2A—conduct disorder	2.91e-05	0.00025	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—HTR2A—conduct disorder	2.9e-05	0.000249	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—HTR2A—conduct disorder	2.89e-05	0.000248	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—HTR2A—conduct disorder	2.87e-05	0.000246	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—HTR2A—conduct disorder	2.86e-05	0.000245	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Metabolism—COMT—conduct disorder	2.85e-05	0.000245	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—CGA—conduct disorder	2.83e-05	0.000243	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Metabolism—MAOA—conduct disorder	2.83e-05	0.000243	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—DRD4—conduct disorder	2.69e-05	0.00023	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—HTR2A—conduct disorder	2.66e-05	0.000228	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—DRD4—conduct disorder	2.64e-05	0.000227	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—DRD4—conduct disorder	2.64e-05	0.000226	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—DRD4—conduct disorder	2.63e-05	0.000226	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—DRD4—conduct disorder	2.62e-05	0.000225	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—DRD4—conduct disorder	2.6e-05	0.000223	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—DRD4—conduct disorder	2.59e-05	0.000222	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—HTR2A—conduct disorder	2.58e-05	0.000221	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—HTR2A—conduct disorder	2.54e-05	0.000218	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—COMT—conduct disorder	2.53e-05	0.000217	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—MAOA—conduct disorder	2.51e-05	0.000215	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Hemostasis—EP300—conduct disorder	2.45e-05	0.00021	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—HTR2A—conduct disorder	2.44e-05	0.000209	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—DRD4—conduct disorder	2.4e-05	0.000206	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—HTR2A—conduct disorder	2.32e-05	0.000199	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—COMT—conduct disorder	2.32e-05	0.000199	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—MAOA—conduct disorder	2.3e-05	0.000197	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—HTR2A—conduct disorder	2.29e-05	0.000196	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—HTR2A—conduct disorder	2.29e-05	0.000196	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—COMT—conduct disorder	2.13e-05	0.000183	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—MAOA—conduct disorder	2.11e-05	0.000181	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—HTR2A—conduct disorder	2.07e-05	0.000177	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—HTR2A—conduct disorder	1.99e-05	0.00017	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—HTR2A—conduct disorder	1.93e-05	0.000166	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—HTR2A—conduct disorder	1.9e-05	0.000163	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—EP300—conduct disorder	1.85e-05	0.000159	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—HTR2A—conduct disorder	1.75e-05	0.00015	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—HTR2A—conduct disorder	1.72e-05	0.000148	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—HTR2A—conduct disorder	1.72e-05	0.000147	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—HTR2A—conduct disorder	1.71e-05	0.000147	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—HTR2A—conduct disorder	1.69e-05	0.000145	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—HTR2A—conduct disorder	1.69e-05	0.000145	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—HTR2A—conduct disorder	1.57e-05	0.000135	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—COMT—conduct disorder	1.51e-05	0.00013	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—MAOA—conduct disorder	1.5e-05	0.000129	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—EP300—conduct disorder	1.37e-05	0.000117	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—EP300—conduct disorder	1.35e-05	0.000116	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—EP300—conduct disorder	1.29e-05	0.000111	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—COMT—conduct disorder	1.28e-05	0.00011	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—MAOA—conduct disorder	1.27e-05	0.000109	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	1.23e-05	0.000106	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—EP300—conduct disorder	1.23e-05	0.000105	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Metabolism—EP300—conduct disorder	1.22e-05	0.000105	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—EP300—conduct disorder	1.21e-05	0.000104	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—EP300—conduct disorder	1.21e-05	0.000104	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—EP300—conduct disorder	1.1e-05	9.4e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—EP300—conduct disorder	1.08e-05	9.29e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—EP300—conduct disorder	1.05e-05	9.02e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—EP300—conduct disorder	1.02e-05	8.78e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—EP300—conduct disorder	1.01e-05	8.64e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—EP300—conduct disorder	9.94e-06	8.53e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—EP300—conduct disorder	9.29e-06	7.96e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—EP300—conduct disorder	9.14e-06	7.84e-05	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—EP300—conduct disorder	9.13e-06	7.83e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—EP300—conduct disorder	9.12e-06	7.82e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—EP300—conduct disorder	9.09e-06	7.79e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—EP300—conduct disorder	9.06e-06	7.77e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—EP300—conduct disorder	8.97e-06	7.69e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—EP300—conduct disorder	8.95e-06	7.67e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—EP300—conduct disorder	8.31e-06	7.13e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—EP300—conduct disorder	6.48e-06	5.56e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—EP300—conduct disorder	5.49e-06	4.71e-05	CbGpPWpGaD
